| Property | Value |
|---|
|
?:abstract
|
-
Introduction: Face to face (F2F) visits in an inner city pediatric (4-18 years) asthma disease management system (Breathmobile) were cancelled and converted to telemedicine encounters during Covid-19 pandemic This “experiment in nature” allowed evaluation of telephone visits in maintaining asthma control in these patients Methods: Patients regularly followed by the Breathmobile were called by their specialist providers during time of their originally scheduled face to face visit Comprehensive asthma specific history was taken including current asthma control test (ACT) score Medications were refilled, inhaler techniques reinforced, and asthma action plans provided We compared ACT scores, show rates and clinical staff workload during telemedicine period to similar period before Covid-19 pandemic Results: Telemedicine data from March 16th 2020 to submission of this abstract were analyzed (4 months) ACT scores remained above 19 during this period with over 90% of patients maintaining asthma control This was statistically not different from ACT scores and percentage of patients in control during same time in 2019 Show rates were significantly higher during the telemedicine period compared to F2F visits Provider and nursing staff reported 32 to 62 percent increase time spend on each patient visit while conducting telemedicine compared to F2F visits (Figure 1) Conclusion: Asthma control can be maintained and show rates actually increased via telephone visits during natural crisis which shut down F2F encounters, although staff may experience higher workloads This care model may be applied to other childhood chronic diseases during periods of emergency/natural crisis [Formula presented]
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Annals_of_Allergy,_Asthma_and_Immunology
-
Annals_of_Allergy_Asthma_&_Immunology
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Inner City Asthma Tele-medicine during Covid Pandemic
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}